ArticleOrphanet journal of rare diseases2015

How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration.

Pat Furlong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.